Patent AnalyticsExaminers
Rankings

Company or institution

Perfuse Therapeutics, Inc.

11 applicationsfiled 2022 to 2025

Allowance rate
n/a
Needs 10 decided cases; has 7
Rejections before allowance
0.8
−0.8 vs the USPTO
Months to first action
9.8 mo
−8.8 vs the USPTO
Needed an RCE
57%
+30 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations9 apps
C07D Heterocyclic compounds2 apps

Art units

OPAP2 apps
16142 apps
16112 apps
16272 apps
16172 apps
16131 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19596815METHODS OF PREPARING DRUG DELIVERY SYSTEMS FORTHE TREATMENT OF OCULAR DISEASES2026-06-12Pending00n/a
19397828TREATMENT OF DIABETIC RETINOPATHY USING ENDOTHELIN RECEPTOR ANTAGONISTS2025-11-21Pending203.1 mo
19232649PHARMACEUTICAL COMPOSITIONS AND INTRAVITREAL DRUG DELIVERY SYSTEMS FOR THE TREATMEN…2025-06-09Pending00n/a
15710601Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15965011Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15309283Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15894265Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15479841Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15825534Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15912480Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 11 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in